-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Toronto Stock Exchange KanadaCADISIN CA05156V1022-
Aurinia PharmaceuticalsBörse Toronto Stock Exchange KanadaCADISIN CA05156V1022
-
EURAurinia PharmaceuticalsBörse Börse Stuttgart
-
AURINIA PHARMACEUTICALS INCBörse Quotrix System der Börse DüsseldorfEURSymbol IKAP
-
AURINIA PHARMACEUTICALS INCBörse Gettex System der Börse MünchenEURSymbol IKAP
-
AURINIA PHARMACEUTICALS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol IKAP
-
ISIN CA05156V1022 WKN: A1W7D4USDSymbol AUPH
-
EUR
-
EUR
-
ISIN CA05156V1022
Firmenname
Aurinia Pharmaceuticals Inc
Marktkapitalisierung
1.567.410.656 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
2.011.821.312 oder 1.123.000.000
Mitarbeiter
178 (+- 65%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
62 oder 294 Mitarbeiter
EBITDA -58.641.000
Buchwert 3.154
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 11,41 EUR -1,72%
ETFs die in Aurinia Pharmaceuticals investieren
Dir gefallen die Informationen zu Aurinia Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Aurinia Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Aurinia Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Aurinia Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
40 News & Informationen zur Aurinia Pharmaceuticals Aktie
Why Aurinia Pharmaceuticals Stock Was Surging on Friday
Investors were relieved to see significant sales from the company's first commercial-stage drug.
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
– $6.6 million in net revenue for the second quarter 2021 (624% increase from first quarter 2021) – – 415 patient start forms (PSFs) received for LUPKYNIS™…
Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript
AUPH earnings call for the period ending June 30, 2021.
Aurinia Pharmaceuticals Inc. (AUPH) CEO John Leonard on Q2 2021 Results – Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2021 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Glenn Schulman – Senior Vice President of Corporate Communications…
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of -5.71% and 32.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Life Sciences BC Announces Annual Award Winners
VANCOUVER, British Columbia — Life Sciences BC is pleased to announce the recipients of the 23rd Annual Life Sciences BC Awards, presented by FARRIS. These…
Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar
Projecting over $33 billion in COVID-19 vaccine revenue alone in 2021, CEO Albert Bourla wants to beef up Pfizer's pipeline.
4 Canadian Stocks to Buy This Week
Motley Fool investors wanting a boost ahead of earnings should consider these four Canadian stocks to buy in the week ahead!
Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for
Aurinia (AUPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TSX falls 0.12% to 20,164.96
* The Toronto Stock Exchange's TSX falls 0.12 percent to 20,164.96
* Leading the index were Lithium Americas Corp , up 6.7%, Stelco Holdings Inc, up 6.4%, and Equinox… | July 26, 2021
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021
VICTORIA, British Columbia — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its second quarter…
Aurinia Pharmaceuticals To Release Second Quarter 2021 Financial Results On August 5, 2021
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its second quarter 2021 financial results on
Is SEMrush Holdings, Inc. (SEMR) A Good Stock To Buy?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their…
Aurinia Pharmaceuticals : Announces Delisting from the Toronto Stock Exchange
Aurinia Pharmaceuticals Inc. , a commercial stage biopharmaceutical company advancing therapies for severe autoimmune diseases, announced today it will voluntarily delist the common shares of the… | July 16, 2021
Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director
Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director Oxford, UK – 15 July, 2021: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or…
TSX Ends Notably Lower
(RTTNews) – The Canadian stock market ended notably lower on Wednesday, dragged down by loss in healthcare, energy and information technology shar…
Hedge Funds Have Never Been This Bullish On Domo Inc. (DOMO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Hedge Funds Are Coming Back To Aurinia Pharmaceuticals Inc (AUPH)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession…
B.C. Sees Record Capital Raising And Market Capitalization During COVID-19 Pandemic
VANCOUVER, BC, July 12, 2021 /CNW/ – The total market value of B.C.'s public companies grew nearly 50 per cent in 2020 to reach record highs, despite the
2 TSX Stocks Bay Street Expects Could Double in July!
There are a few factors to know whether a stock could double in the next month, and these two hit all the boxes for Motley Fool investors.
Canadian Market Down In Negative Territory As Energy Stocks Tumble
(RTTNews) – The Canadian stock market is down in negative territory, having slumped after a slightly positive start Tuesday morning. Firm bullio…
3 Canadian Stocks to Buy Now at Dirt-Cheap Prices
These are the top Canadian stocks to buy now or at least consider before the market realizes just how dirt cheap they really are!
3 Undervalued Stocks That Are Screaming Buys Right Now
If you're looking for undervalued stocks, these are the ones to buy for long-term investment and incredible gains in the near and far future.
TSX flat after dismal growth data, set for fifth straight monthly gains
Canada’s main stock index remained muted on Wednesday, while official data showed the nation’s economy likely contracted again in May, following its first…
Aurinia Pharmaceuticals : Awards $250,000 in Grants to Support Patient Navigation Programs
Five patient organizations will receive funds to implement plans aimed at reducing health disparities, connecting people living with systemic lupus erythematosus and lupus nephritis with needed… | June 30, 2021
Aurinia Awards $250,000 In Grants To Support Patient Navigation Programs
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the Company) today announced the recipients of five $50,000 grant awards to support implementation
TSX rises 0.13% to 20,171.02
* The Toronto Stock Exchange's TSX rises 0.13 percent to 20,171.02
* Leading the index were Corus Entertainment Inc , up 6.6%, Cargojet Inc, up 5.3%, and Gildan… | June 29, 2021
Aurinia Pharmaceuticals : Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA)
Aurinia Pharmaceuticals Inc. announced today that the Company’s licensing partner, Otsuka Pharmaceutical Europe Ltd. , filed an initial Marketing Authorization Application for voclosporin… | June 25, 2021
Gritstone Announces Management Changes, Including
EMERYVILLE, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next…
Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference
Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference | Nachricht | finanzen.net
Aurinia Pharmaceuticals To Present At The Bloom Burton & Co. Healthcare Investor Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in a
The Week Ahead In Biotech: FDA To Issue Decisions On Merck And Aurinia Drug Applications
Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in, with most …
The Week Ahead In Biotech: FDA To Issue Decisions On Merck And Aurinia Drug Applications
Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in,…
TSX Ends Marginally Higher
(RTTNews) – The Canadian stock market ended on a positive note on Thursday after staying firm right through the session. Strong gains in healthcar…
Canadian Market Remains In Positive Territory After Steady Start
(RTTNews) – The Canadian stock market remains fairly well placed in positive territory a little past noon on Thursday thanks to strong gains in he…
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options
Investors need to pay close attention to Aurinia Pharmaceuticals (AUPH) stock based on the movements in the options market lately.
Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences
VICTORIA, British Columbia — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will…
Insider trading: January 4, 2021
The following is a list of stock trades made by corporate executives, directors and other company insiders of B.C.’s public companies filed in the week ended Dec 23, 2020.
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Year-end reviews by the Food and Drug Administration produced mostly positive outcomes, with most therapies passing the regulatory hurdle without …
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Year-end reviews by the Food and Drug Administration produced mostly positive outcomes, with most therapies passing the regulatory hurdle without any …